Tomoko Yamazaki
Publications by Year
Research Areas
TGF-β signaling in diseases, Breast Cancer Treatment Studies, Chronic Kidney Disease and Diabetes, Angiogenesis and VEGF in Cancer, Adipokines, Inflammation, and Metabolic Diseases
Most-Cited Works
- → Snail is required for TGFβ-induced endothelial-mesenchymal transition of embryonic stem cell-derived endothelial cells(2008)308 cited
- → Apoptosis inhibitor of macrophage protein enhances intraluminal debris clearance and ameliorates acute kidney injury in mice(2016)222 cited
- → TGFβ suppresses CD8+ T cell expression of CXCR3 and tumor trafficking(2020)209 cited
- → Tissue Specific Origin, Development, and Pathological Perspectives of Pericytes(2018)179 cited
- → Force-triggered rapid microstructure growth on hydrogel surface for on-demand functions(2022)119 cited
- → Bone morphogenetic protein-9 inhibits lymphatic vessel formation via activin receptor-like kinase 1 during development and cancer progression(2013)109 cited
- → Blockade of fibroblast activation protein in combination with radiation treatment in murine models of pancreatic adenocarcinoma(2019)65 cited
- → Macrophage fatty acid oxidation inhibits atherosclerosis progression(2019)57 cited
- → MicroRNA‐31 is a positive modulator of endothelial–mesenchymal transition and associated secretory phenotype induced by TGF‐β(2015)52 cited
- → Control elements of Dnmt1 gene are regulated in cell-cycle dependent manner(2003)39 cited